EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Surgical Perspectives on Neoadjuvant Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer

Jingcheng Zhang iD, Menghang Geng, Helmut Friess, Ihsan Ekin Demir iD, Florian Scheufele

Cancers · 01.04.2026 · 18 (7) · 1131

DOI: 10.3390/cancers18071131 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 01.04.2026. Verfasst von Jingcheng Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Klinikum Rechts der Isar, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany. Die Arbeit nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Neoadjuvant therapy (NAT) is now central to the management of borderline resectable (BRPC) and locally advanced (LAPC) pancreatic ductal adenocarcinoma (PDAC). This narrative review summarizes contemporary evidence and guidelines from a surgical perspective, with emphasis on pretreatment classification, post-NAT selection for exploration, intraoperative vascular strategy, and postoperative management.

Methods

We conducted a structured narrative review of randomized and prospective studies, high-quality observational cohorts, and major international guidelines published through 31 July 2025.

Results

BRPC and LAPC remain primarily defined by vascular anatomy, but biologic and conditional factors are increasingly integrated into decision-making. NAT is the preferred initial strategy for BRPC and the standard induction approach for LAPC, with resection considered only in carefully selected responders. After NAT, contrast-enhanced CT combined with CA19-9 kinetics remains the core restaging platform, while FDG-PET, diffusion-weighted MRI, radiomics, and circulating biomarkers may serve as adjuncts in equivocal cases. Surgical exploration should be guided by physiologic recovery, the absence of metastatic progression, and multidisciplinary reassessment. Staging laparoscopy remains useful for detecting occult metastatic disease. Intraoperatively, vascular resection should be margin-driven rather than routine, with portal–mesenteric venous resection established in expert centers, whereas arterial resection remains highly selective. Periarterial divestment represents an artery-sparing alternative in selected cases. NAT does not appear to worsen short-term postoperative outcomes, but anticoagulation after venous reconstruction remains non-standardized.

Conclusions

NAT has transformed BRPC/LAPC PDAC into a biology-gated, time-sequenced surgical pathway. Standardized reassessment, careful candidate selection, and the centralization of complex vascular procedures are essential to optimize outcomes.

Schlagwörter

Stichwörter der Autor:innen

borderline resectableconversion surgerylocally advancedneoadjuvant therapypancreatic ductal adenocarcinoma

Autor:innen und Institutionen

  • Department of Surgery, Klinikum Rechts der Isar, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.

ORCID-Profile: Jingcheng Zhang, Ihsan Ekin Demir

Zitieren

APA

Zhang, J., Geng, M., Friess, H., Demir, I. E., & Scheufele, F. (2026). Surgical Perspectives on Neoadjuvant Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer. Cancers, 18(7), 1131. https://doi.org/10.3390/cancers18071131

Vancouver

Zhang J, Geng M, Friess H, Demir IE, Scheufele F. Surgical Perspectives on Neoadjuvant Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer. Cancers. 2026;18(7):1131. doi:10.3390/cancers18071131

BibTeX
@article{Zhang2026,
  author = {Zhang, Jingcheng and Geng, Menghang and Friess, Helmut and Demir, Ihsan Ekin and Scheufele, Florian},
  title = {Surgical Perspectives on Neoadjuvant Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {1131},
  doi = {10.3390/cancers18071131}
}
Kostenlos starten →